Genmab A/S (CPH:GMAB)
1,364.00
-35.00 (-2.50%)
Mar 28, 2025, 4:59 PM CET
Genmab Employees
Genmab had 2,682 employees as of December 31, 2024. The number of employees increased by 478 or 21.69% compared to the previous year.
Employees
2,682
Change (1Y)
478
Growth (1Y)
21.69%
Revenue / Employee
8.03M DKK
Profits / Employee
2.92M DKK
Market Cap
86.68B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Novo Nordisk | 77,349 |
Coloplast | 16,639 |
Demant | 22,639 |
Zealand Pharma | 335 |
H. Lundbeck | 5,707 |
Ambu A/S | 5,196 |
ALK-Abelló | 2,753 |
GN Store Nord | 7,347 |
Genmab News
- 3 days ago - Japanese Drug Regulator Approves Genmab Cancer Drug For Patients With Advanced Cervical Cancer - Benzinga
- 3 days ago - Japanese Drug Regulator Approves Genmab Cancer Drug For Patients With Advanced Cervical Cancer - Benzinga
- 3 days ago - Genmab and BridgeBio Pharma announce Japan approval for their treatments - Seeking Alpha
- 3 days ago - TIVDAK® (tisotumab vedotin) Approved by Japan Ministry of Health, Labour and Welfare for the Treatment of Advanced or Recurrent Cervical Cancer that has Progressed on or after Chemotherapy - Business Wire
- 3 days ago - TIVDAK® (tisotumab vedotin) Approved by Japan Ministry of Health, Labour and Welfare for the Treatment of Advanced or Recurrent Cervical Cancer that has Progressed on or after Chemotherapy - GlobeNewsWire
- 5 days ago - Genmab Announces Initiation of Share Buy-Back Program - GlobeNewsWire
- 9 days ago - Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc. - GlobeNewsWire
- 10 days ago - DARZALEX Continues to Redefine Multiple Myeloma Treatment with Robust Market Performance | DelveInsight - Benzinga